美国 · SEC FORM 4
NEUROCRINE BIOSCIENCES INC
NBIX · Nasdaq · CIK 0000914475 · Healthcare · Drug Manufacturers—Specialty & Generic
内部人信号
0 qualifying P purchase groups
当前 180 天评分窗口
84 同一窗口内观察到的 Form 4 交易行
30 sales · 54 期权、代扣税、授予、赠与或其他交易行
为什么没有活跃信号？
评分构成
活跃窗口内没有合资格买入，因此不计算分数。缺失的输入不会被当作零分或看空信号。
为什么没有分数？
- 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
- 卖出及其他 Form 4 活动继续作为背景显示，不会形成负分。
卖出和其他 Form 4 活动会单独显示，不会形成负面买入信号。没有买入不会被评分为看空。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。
Showing the six most active owners; 7 additional owner(s) remain in Form 4 申报证据.
买方广度、集中度与聚集买入
合资格买入进入 180 天研究窗口后，这些模块才会启用。
信号历史
Scores are archived only when the company qualifies for a published US buy-signal snapshot.—
近期 Form 4 活动
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
该股票尚未获取市场背景。每日任务会轮转处理美国股票池。
空头余额
空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。
- 空头股数
- 5,853,128
- 上期报告
- 4,964,907
- 日均成交量
- 1,476,037
- 回补天数
- 4.0
FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。
历史股票买入
本地 Form 4 历史中没有合资格的代码 P 股票买入。
Form 4 申报证据
199 transaction lines in the latest 365-day window; 879 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-09-14 | Boyer David W. | 卖出 (S) | Common Stock | 826 | USD 157.45 | USD 130,054 | SEC 申报 ↗ |
| 2026-09-14 | ABERNETHY MATT | 卖出 (S) | Common Stock | 2,311 | USD 157.20 | USD 363,289 | SEC 申报 ↗ |
| 2026-09-11 | Onyia Jude | 代扣税 (F) | Common Stock | 1,936 | USD 156.22 | USD 302,442 | SEC 申报 ↗ |
展开近期 Form 4 证据 (30 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-09-14 | Boyer David W. | 卖出 (S) | Common Stock | 826 | USD 157.45 | USD 130,054 | SEC 申报 ↗ |
| 2026-09-14 | ABERNETHY MATT | 卖出 (S) | Common Stock | 2,311 | USD 157.20 | USD 363,289 | SEC 申报 ↗ |
| 2026-09-11 | Onyia Jude | 代扣税 (F) | Common Stock | 1,936 | USD 156.22 | USD 302,442 | SEC 申报 ↗ |
| 2026-09-11 | Onyia Jude | 奖励／授予 (A) | Common Stock | 3,587 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-09-11 | Lippoldt Darin | 代扣税 (F) | Common Stock | 2,419 | USD 156.22 | USD 377,896 | SEC 申报 ↗ |
| 2026-09-11 | Lippoldt Darin | 奖励／授予 (A) | Common Stock | 4,483 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-09-11 | Keswani Sanjay Chandru | 代扣税 (F) | Common Stock | 2,112 | USD 156.22 | USD 329,937 | SEC 申报 ↗ |
| 2026-09-11 | Keswani Sanjay Chandru | 奖励／授予 (A) | Common Stock | 3,914 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-09-11 | Gano Kyle | 代扣税 (F) | Common Stock | 4,380 | USD 156.22 | USD 684,244 | SEC 申报 ↗ |
| 2026-09-11 | Gano Kyle | 奖励／授予 (A) | Common Stock | 8,117 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-09-11 | GORMAN KEVIN CHARLES | 代扣税 (F) | Common Stock | 7,839 | USD 156.22 | USD 1,224,609 | SEC 申报 ↗ |
| 2026-09-11 | GORMAN KEVIN CHARLES | 奖励／授予 (A) | Common Stock | 14,343 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-09-11 | Delaet Ingrid | 代扣税 (F) | Common Stock | 2,419 | USD 156.22 | USD 377,896 | SEC 申报 ↗ |
| 2026-09-11 | Delaet Ingrid | 奖励／授予 (A) | Common Stock | 4,483 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-09-11 | Cooke Julie | 代扣税 (F) | Common Stock | 1,936 | USD 156.22 | USD 302,442 | SEC 申报 ↗ |
| 2026-09-11 | Cooke Julie | 奖励／授予 (A) | Common Stock | 3,587 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-09-11 | Boyer David W. | 代扣税 (F) | Common Stock | 1,936 | USD 156.22 | USD 302,442 | SEC 申报 ↗ |
| 2026-09-11 | Boyer David W. | 奖励／授予 (A) | Common Stock | 3,587 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-09-11 | BENEVICH ERIC | 代扣税 (F) | Common Stock | 3,386 | USD 156.22 | USD 528,961 | SEC 申报 ↗ |
| 2026-09-11 | BENEVICH ERIC | 奖励／授予 (A) | Common Stock | 6,275 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-09-11 | ABERNETHY MATT | 代扣税 (F) | Common Stock | 2,709 | USD 156.22 | USD 423,200 | SEC 申报 ↗ |
| 2026-09-11 | ABERNETHY MATT | 奖励／授予 (A) | Common Stock | 5,020 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-09-09 | BENEVICH ERIC | 卖出 (S) | Common Stock | 2,154 | USD 154.61 | USD 333,030 | SEC 申报 ↗ |
| 2026-09-09 | BENEVICH ERIC | 期权行权／转换 (M) | Common Stock | 3,194 | USD 43.24 | USD 138,109 | SEC 申报 ↗ |
| 2026-09-02 | SHERWIN STEPHEN A | 赠与 (G) | Common Stock | 1,000 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-08-04 | Onyia Jude | 赠与 (G) | Common Stock | 2,409 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-07-29 | Norwalk Leslie V | 期权行权／转换 (M) | Common Stock | 842 | USD 139.43 | USD 117,400 | SEC 申报 ↗ |
| 2026-07-28 | Norwalk Leslie V | 卖出 (S) | Common Stock | 1,250 | USD 182.01 | USD 227,512 | SEC 申报 ↗ |
| 2026-07-10 | Delaet Ingrid | 卖出 (S) | Common Stock | 4,367 | USD 181.02 | USD 790,514 | SEC 申报 ↗ |
| 2026-07-10 | Delaet Ingrid | 期权行权／转换 (M) | Common Stock | 4,367 | USD 106.02 | USD 462,989 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-18 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | NBIX |
| CIK | 0000914475 |
| 行业 | Healthcare |
| 细分行业 | Drug Manufacturers—Specialty & Generic Yahoo Finance |
| SEC SIC | 2836 Biological Products, (No Diagnostic Substances) |
| 交易所 | Nasdaq |
数据覆盖
| 本地 Form 4 历史 | 879 transaction lines from 2020-01-08 to 2026-09-14 0 P purchase lines · 506 S sale lines · 373 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.